Device Trial Radar · NCT06352684
Effectiveness of CadAI-B for Breast
Last checked: Nov 19, 2026Latest source record: Sep 30, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,000
Actual
Start
Nov 24, 2023
Primary completion
Jul 1, 2024
Study completion Aug 21, 2025
Sponsor
- Lead sponsor
- BeamWorks Inc.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Severance Hospital
- First posted
- Apr 8, 2024
Design
- Study type
- Observational
- FDA-regulated device
- Yes
- Who can join
- Female only, from 19 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the effectiveness of lesion detection and diagnosis-aiding software (CadAI-B for Breast) during ultrasound (US) examination
Conditions
- Breast Cancer
Interventions
CadAI-B for BreastDevice
CadAI-B for Breast is designed to assist healthcare professionals in lesion detection and differential diagnosis during breast US examinations.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Area Under the LROC CurveTime frame: 6 weeks
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Yonsei University Severance Hospital
Seoul, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.